VOR Vor Biopharma
Vor Biopharma earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 12 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by VOR's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $66M sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Ra Capital Management, L.P. 10% owner, +3 joint filersSale$4,207 213 shares at $19.75 <0.1% of stakeTraded Jul 16 Filed Jul 21
-
Ra Capital Management, L.P. Director, +3 joint filersSale$2.6M 165,150 shares at $15.77 6.4% of stakeTraded Apr 22 Filed Apr 24
-
Ra Capital Management, L.P. Director, +3 joint filersSale$10.2M 630,374 shares at $16.14 20% of stakeTraded Apr 17–20 Filed Apr 21
-
Ra Capital Management, L.P. Director, +3 joint filersSale$11.9M 737,989 shares at $16.10 19% of stakeTraded Apr 13–15 Filed Apr 15
-
Ra Capital Management, L.P. Director, +3 joint filersSale$10.2M 620,133 shares at $16.50 14% of stakeTraded Apr 8–10 Filed Apr 10
-
Ra Capital Management, L.P. Director, +3 joint filersSale$14.5M 849,257 shares at $17.10 16% of stakeTraded Apr 2–6 Filed Apr 6
-
Ra Capital Management, L.P. Director, +3 joint filersSale$10.4M 400,408 shares at $25.90 34% of stakeTraded Oct 28–30 Filed Oct 30, 2025
-
Ra Capital Management, L.P. Director, +3 joint filersSale$6.2M 221,166 shares at $28.06 16% of stakeTraded Oct 23–27 Filed Oct 27, 2025
-
Ra Capital Management, L.P. Director, +4 joint filersSale$3.4M 117,050 shares at $29.34 7.7% of stakeTraded Oct 20–21 Filed Oct 22, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerSale$1.1M 37,533 shares at $30.19 3.1% of stakeTraded Oct 17–21 Filed Oct 21, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerSale$2.3M 73,676 shares at $31.88 5.8% of stakeTraded Oct 15–16 Filed Oct 17, 2025
-
Ra Capital Management, L.P. Director, +4 joint filersSale$13.7M 464,025 shares at $29.54 97% of stakeTraded Oct 15–17 Filed Oct 17, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerSale$3M 96,657 shares at $31.08 7% of stakeTraded Oct 10–14 Filed Oct 15, 2025
-
Reprogrammed Interchange LLC 10% owner, +1 joint filerSale$4.1M 124,146 shares at $33.16 8.3% of stakeTraded Oct 8–9 Filed Oct 10, 2025
Also filed in the last 12 months, not counted as buying or selling: 3 option exercises, 1 stock grant, and 1 sale back to the company.
SEC filings
Recent issuer filings from EDGAR, 23 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.